NEW YORK (GenomeWeb) – The National Cancer Institute and US Food and Drug Administration said today they have signed a memorandum of understanding to collaborate on proteogenomic cancer research.

According to the agencies, the MOU will allow them "to share information that will accelerate the development of proteogenomic technologies and biomarkers, as it relates to precision medicine in cancer."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.